HRA005803
Title:
a multi-cancer detection and localization approach using circulating tumor DNA methylation markers
Release date:
2023-10-18
Description:
We performed enzymatic conversion-based targeted methylation sequencing on plasma cfDNA samples collected from a clinical cohort of 500 healthy controls and 733 cancer patients with seven types of cancer (breast, colorectum, esophagus, stomach, liver, lung, and pancreas) and randomly divided these samples into a training cohort and a testing cohort. An independent validation cohort of 143 healthy controls, 79 liver cancer patients and 100 stomach cancer patients were recruited to validate the generalizability of our approach.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Cohort Study
Disease name:
cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Data Access Committee of TOTEM
Contact person:
Li Chunguang
Email:
lcg_gc@163.com
Description:
This Committee responsible for data release of the project to external requestors based on consent and/or National Research Ethics terms.
Individuals & samples
Submitter:   Li Chunguang / lcg_gc@163.com
Organization:   Zhongnan Hospital of Wuhan University
Submission date:   2023-10-07
Requests:   3